BCG in tumor immunotherapy.
D000276:Adjuvants, Immunologic; D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006168:Guinea Pigs; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D007938:Leukemia / Q000628:therapy; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D051379:Mice; D012157:Mononuclear Phagocyte System / Q000276:immunology; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D010586:Phagocytes / Q000276:immunology; D012878:Skin Neoplasms / Q000276:immunology
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D001500:BCG Vaccine